Joel Gelernter1,2,3, Hang Zhou1,2, Yaira Z Nuñez1,2, Apiwat Mutirangura4, Robert T Malison1,5, Rasmon Kalayasiri6,7. 1. Department of Psychiatry , Yale University School of Medicine, New Haven, Connecticut. 2. Department of Psychiatry , VA Connecticut Healthcare System, West Haven, Connecticut. 3. Departments of Genetics and Neuroscience , Yale University School of Medicine, New Haven, Connecticut. 4. Department of Anatomy , Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. 5. Clinical Neuroscience Research Unit , Connecticut Mental Health Center, New Haven, Connecticut. 6. Department of Psychiatry , King Chulalongkorn Memorial Hospital, Bangkok, Thailand. 7. Department of Psychiatry , Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Abstract
BACKGROUND: Alcohol use (both quantity and dependence) is moderately heritable, and genomewide association studies (GWAS) have identified risk genes in European, African, and Asian populations. The most reproducibly identified risk genes affect alcohol metabolism. Well-known functional variants at the gene encoding alcohol dehydrogenase B and other alcohol dehydrogenases affect risk in European and African ancestry populations. Similarly, variants mapped to these same genes and a well-known null variant that maps to the gene that encodes aldehyde dehydrogenase 2 (ALDH2) also affect risk in various Asian populations. In this study, we completed the first GWAS for 3 traits related to alcohol use in a Thai population recruited initially for studies of methamphetamine dependence. METHODS: All subjects were evaluated with the Thai version of the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA). A total of 1,045 subjects were available for analysis. Three traits were analyzed: flushing, maximum number of alcoholic beverages consumed in any lifetime 24-hour period ("MAXDRINKS"), and DSM-IV alcohol dependence criterion count. We also conducted a pleiotropy analysis with major depression, the only other psychiatric trait where summary statistics from a large-scale Asian-population GWAS are available. RESULTS: All 3 traits showed genomewide significant association with variants near ALDH2, with significance ranging from 2.01 × 10-14 (for flushing; lead single nucleotide polymorphism (SNP) PTPN11* rs143894582) to pmeta = 5.80 × 10-10 (for alcohol dependence criterion count; lead SNP rs149212747). These lead SNPs flank rs671 and span a region of over a megabase, illustrating the need for prior biological information in identifying the actual effect SNP, rs671. We also identified significant pleiotropy between major depression and flushing. CONCLUSIONS: These results are consistent with prior findings in Asian populations and add new information regarding alcohol use-depression pleiotropy.
BACKGROUND:Alcohol use (both quantity and dependence) is moderately heritable, and genomewide association studies (GWAS) have identified risk genes in European, African, and Asian populations. The most reproducibly identified risk genes affect alcohol metabolism. Well-known functional variants at the gene encoding alcohol dehydrogenase B and other alcohol dehydrogenases affect risk in European and African ancestry populations. Similarly, variants mapped to these same genes and a well-known null variant that maps to the gene that encodes aldehyde dehydrogenase 2 (ALDH2) also affect risk in various Asian populations. In this study, we completed the first GWAS for 3 traits related to alcohol use in a Thai population recruited initially for studies of methamphetamine dependence. METHODS: All subjects were evaluated with the Thai version of the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA). A total of 1,045 subjects were available for analysis. Three traits were analyzed: flushing, maximum number of alcoholic beverages consumed in any lifetime 24-hour period ("MAXDRINKS"), and DSM-IV alcohol dependence criterion count. We also conducted a pleiotropy analysis with major depression, the only other psychiatric trait where summary statistics from a large-scale Asian-population GWAS are available. RESULTS: All 3 traits showed genomewide significant association with variants near ALDH2, with significance ranging from 2.01 × 10-14 (for flushing; lead single nucleotide polymorphism (SNP) PTPN11* rs143894582) to pmeta = 5.80 × 10-10 (for alcohol dependence criterion count; lead SNP rs149212747). These lead SNPs flank rs671 and span a region of over a megabase, illustrating the need for prior biological information in identifying the actual effect SNP, rs671. We also identified significant pleiotropy between major depression and flushing. CONCLUSIONS: These results are consistent with prior findings in Asian populations and add new information regarding alcohol use-depression pleiotropy.
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: Hamdi Mbarek; Yuri Milaneschi; Iryna O Fedko; Jouke-Jan Hottenga; Marleen H M de Moor; Rick Jansen; Joel Gelernter; Richard Sherva; Gonneke Willemsen; Dorret I Boomsma; Brenda W Penninx; Jacqueline M Vink Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2015-09-14 Impact factor: 3.568
Authors: Ellen E Quillen; Xiang-Ding Chen; Laura Almasy; Fang Yang; Hao He; Xi Li; Xu-Yi Wang; Tie-Qiao Liu; Wei Hao; Hong-Wen Deng; Henry R Kranzler; Joel Gelernter Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2013-11-26 Impact factor: 3.568
Authors: Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis Journal: Nature Date: 2015-10-01 Impact factor: 49.962
Authors: T-K Clarke; M J Adams; G Davies; D M Howard; L S Hall; S Padmanabhan; A D Murray; B H Smith; A Campbell; C Hayward; D J Porteous; I J Deary; A M McIntosh Journal: Mol Psychiatry Date: 2017-07-25 Impact factor: 15.992
Authors: Joel Gelernter; Ning Sun; Renato Polimanti; Robert H Pietrzak; Daniel F Levey; Qiongshi Lu; Yiming Hu; Boyang Li; Krishnan Radhakrishnan; Mihaela Aslan; Kei-Hoi Cheung; Yuli Li; Nallakkandi Rajeevan; Fred Sayward; Kelly Harrington; Quan Chen; Kelly Cho; Jacqueline Honerlaw; Saiju Pyarajan; Todd Lencz; Rachel Quaden; Yunling Shi; Haley Hunter-Zinck; J Michael Gaziano; Henry R Kranzler; John Concato; Hongyu Zhao; Murray B Stein Journal: Biol Psychiatry Date: 2019-04-08 Impact factor: 13.382
Authors: Dongbing Lai; Leah Wetherill; Manav Kapoor; Emma C Johnson; Melanie Schwandt; Vijay A Ramchandani; David Goldman; Geoff Joslyn; Xi Rao; Yunlong Liu; Sean Farris; R Dayne Mayfield; Danielle Dick; Victor Hesselbrock; John Kramer; Vivia V McCutcheon; John Nurnberger; Jay Tischfield; Alison Goate; Howard J Edenberg; Bernice Porjesz; Arpana Agrawal; Tatiana Foroud; Marc Schuckit Journal: Addict Biol Date: 2019-07-03 Impact factor: 4.280